We only have this paper's title and publication details.
Read it at the sourceAnswers are grounded in this paper and cite their sources.
UCAR T cells can overcome antigenic heterogeneity in GBM and lead to improved treatment outcomes.
No takes yet. Share an insight, caveat, or question.
Bielamowicz et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: